The complete response letter (CRL) specifies that the current dosage duration of aflibercept is still safe but extending the duration is not approved. High-dose aflibercept can be used in DME ...

In its first-quarter 2025 investor letter, Upslope Capital Management highlighted stocks such as Charles River Laboratories International, Inc. (NYSE:CRL). Charles River Laboratories International ...

In trading on Tuesday, shares of Charles River Laboratories International Inc. (Symbol: CRL) entered into oversold territory, hitting an RSI reading of 29.8, after changing hands as low as $105.18 ...

In this article, we are going to take a look at where Charles River Laboratories International, Inc. (NYSE:CRL) stands against other mid-cap stocks insiders were buying in Q1 2025. Stock markets ...